121 related articles for article (PubMed ID: 31848297)
1. Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1α in Prostate Cancer Cells.
Biswas K; Sarkar S; Said N; Brautigan DL; Larner JM
Mol Cancer Ther; 2020 Apr; 19(4):1008-1017. PubMed ID: 31848297
[TBL] [Abstract][Full Text] [Related]
2. Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP.
Sarkar S; Brautigan DL; Larner JM
Mol Cancer Res; 2017 Aug; 15(8):1063-1072. PubMed ID: 28536143
[TBL] [Abstract][Full Text] [Related]
3. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
4. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract][Full Text] [Related]
5. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
6. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
Chen K; Chen S; Huang C; Cheng H; Zhou R
Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
[TBL] [Abstract][Full Text] [Related]
7. HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity.
Parmakhtiar B; Burger RA; Kim JH; Fruehauf JP
Mol Cancer Res; 2019 Aug; 17(8):1675-1686. PubMed ID: 31088908
[TBL] [Abstract][Full Text] [Related]
8. FBXO30 functions as a tumor suppressor and an E3 ubiquitin ligase for hZIP1‑mediated HIF‑1α degradation in renal cell carcinoma.
Yuan Y; Liu Z; Li B; Gong Z; Piao C; Liu Z; Zhang Z; Dong X
Int J Oncol; 2023 Mar; 62(3):. PubMed ID: 36799168
[TBL] [Abstract][Full Text] [Related]
9. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
[TBL] [Abstract][Full Text] [Related]
10. Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer.
Schecher S; Walter B; Falkenstein M; Macher-Goeppinger S; Stenzel P; Krümpelmann K; Hadaschik B; Perner S; Kristiansen G; Duensing S; Roth W; Tagscherer KE
Int J Cancer; 2017 Oct; 141(8):1643-1653. PubMed ID: 28670704
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase USP35 as a novel mitotic regulator via maintenance of Aurora B stability.
Park J; Song EJ
BMB Rep; 2018 Jun; 51(6):261-262. PubMed ID: 29764563
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
Li Y; Zhang D; Wang X; Yao X; Ye C; Zhang S; Wang H; Chang C; Xia H; Wang YC; Fang J; Yan J; Ying H
Sci Rep; 2015 Jul; 5():12495. PubMed ID: 26205124
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.
Sarkar S; Brautigan DL; Parsons SJ; Larner JM
Oncogene; 2014 Jan; 33(1):26-33. PubMed ID: 23246967
[TBL] [Abstract][Full Text] [Related]
15. HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.
Marhold M; Tomasich E; El-Gazzar A; Heller G; Spittler A; Horvat R; Krainer M; Horak P
Mol Cancer Res; 2015 Mar; 13(3):556-64. PubMed ID: 25349289
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer.
Cheng L; Zang J; Dai HJ; Li F; Guo F
Int J Oncol; 2018 Jul; 53(1):203-214. PubMed ID: 29693147
[TBL] [Abstract][Full Text] [Related]
17. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
18. The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.
Biswas K; Sarkar S; Du K; Brautigan DL; Abbas T; Larner JM
Mol Cancer Res; 2017 Jun; 15(6):651-659. PubMed ID: 28232384
[TBL] [Abstract][Full Text] [Related]
19. β-TrCP upregulates HIF-1 in prostate cancer cells.
Cohen M; Amir S; Golan M; Ben-Neriah Y; Mabjeesh NJ
Prostate; 2019 Mar; 79(4):403-413. PubMed ID: 30488478
[TBL] [Abstract][Full Text] [Related]
20. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
